Keywords: مهار بازرسی ایمن; Cytoreductive nephrectomy; Immune checkpoint inhibition; Compete response; Renal cell carcinoma; CT; computed tomography; PD-1; programmed death-1; PD-L1; programmed death ligand-1; RCC; renal cell carcinoma; CNx; cytoreductive nephrectomy;